Usana Health Sciences INC Form 4 insider transactions

USANA Health Sciences Director Gilbert A. Fuller reported the acquisition of 1,058 shares of common stock and 1,058 restricted stock units on January 22, 2026.

USANA Health Sciences Director John T. Fleming acquired 1,058 shares of common stock through the vesting of restricted stock units.

USANA Health Sciences Director Xia Ding reported the vesting of restricted stock units and subsequent sale of shares for tax purposes on January 22, 2026.

USANA Health Sciences' Chief Sales Officer, David Mulham, reported a planned future sale of 873 shares of common stock at $21 per share under a Rule 10b5-1 plan.

USANA Health Sciences' Chief Information Officer, Peter Benedict, sold 2,673 shares of common stock for approximately $20.95 per share under a pre-planned trading arrangement.

USANA Health Sciences Director Frederic J. Winssinger sold 2,000 shares of common stock for $19.21 per share in a pre-planned transaction.

USANA Health Sciences Director Gilbert A. Fuller sold 1,057 shares of common stock for approximately $21.48 per share.

USANA Health Sciences Director John Turman Fleming sold 1,750 shares of common stock at $19.79 per share, reducing his direct beneficial ownership to 4,565 shares.

USANA Health Sciences Director Peggie Pelosi reported the exercise of restricted stock units and subsequent sale of common stock for tax purposes.

USANA Health Sciences Director Timothy Wood reported the acquisition of common stock through RSU vesting and a subsequent sale for tax purposes.

USANA Health Sciences Director Frederic J Winssinger acquired 1,057 shares of common stock through the conversion of restricted stock units, increasing his direct beneficial ownership.

USANA Health Sciences Director J Scott Nixon converted 1,057 restricted stock units into common stock, increasing his direct share ownership.

USANA Health Sciences Director Gilbert A. Fuller converted 1,057 restricted stock units into common stock on October 23, 2025.

USANA Health Sciences Director John Turman Fleming acquired 1,057 shares of common stock through the exercise of restricted stock units on October 23, 2025.

USANA Health Sciences Director Ding Xia reported the acquisition of 1,057 common shares through RSU vesting and the disposition of 476 shares for tax purposes.

USANA Health Sciences Director and 10% owner Myron W. Wentz gifted 145,000 shares of common stock through Gull Global Limited.

USANA Health Sciences Director Gilbert A. Fuller plans to sell all 1,058 shares of common stock on August 7, 2025, at $29.1014 per share.

USANA Health Sciences' Chief Sales Officer, David Mulham, has reported a future sale of 3,515 shares of common stock at $30.26 per share, scheduled for July 30, 2025, under a Rule 10b5-1 trading plan.

USANA Health Sciences' Chief Scientific Officer, Kathryn Michelle Armstrong, acquired 1,165 shares of common stock through RSU vesting and subsequently sold 517 shares to cover tax obligations.

USANA Health Sciences Chief Information Officer Peter Benedict reported the acquisition of 598 common shares through restricted stock unit vesting and the subsequent disposition of 176 shares for tax purposes.

USANA Health Sciences CEO and President Jim Brown reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

USANA Health Sciences Director Ding Xia reported the vesting of 1,058 restricted stock units and the subsequent disposition of 265 shares to cover tax obligations.

USANA Health Sciences Director John Turman Fleming converted 1,058 restricted stock units into common stock, increasing his direct ownership.

USANA Health Sciences Director Gilbert A. Fuller acquired 1,058 shares of common stock through the vesting of restricted stock units.

USANA Health Sciences Director Peggie Pelosi converted restricted stock units into common shares and sold a portion for tax withholding, resulting in a net increase in her direct share ownership.

USANA Health Sciences Director J. Scott Nixon acquired 1,058 shares of common stock on July 24, 2025, through the vesting of restricted stock units.

USANA Health Sciences Inc. Director Frederic J. Winssinger acquired 1,058 shares of common stock through the conversion of restricted stock units, increasing his direct beneficial ownership.

USANA Health Sciences Director Timothy E. Wood acquired common stock through RSU conversion and subsequently sold a portion for tax obligations.

USANA Health Sciences Director John Turman Fleming sold 500 shares of common stock for approximately $29.66 per share on June 9, 2025, under a Rule 10b5-1 trading plan.

USANA Health Sciences' Chief Operating Officer, Walter Noot, reported the sale of 6,291 shares of common stock on May 27, 2025, through a Rule 10b5-1 trading plan, resulting in zero beneficial ownership.